Edwards Lifesciences Corp (NYSE: EW) stock closed at $59.70 on 7/25/24 after a major decline of -31.3%. Moreover, this decline was accompanied by exceptionally high trading volume at 1206% of normal. The stock has declined -31.6% during the last week but has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
EW’s future returns on capital are forecasted to exceed the cost of capital. Accordingly, the company is expected to continue to be a major Value Builder.
Edwards Lifesciences has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Edwards Lifesciences has a poor Appreciation Score of 18 but a good Power Rating of 82, with the Neutral Value Trend Rating the result.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment